A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Fullerene Soot | Fullerene Soot is a fine powder composed of a mix of C60 and C70 fullerenes in a ration of roughly 22% C60 to 76% C70. Fullerene Soot is generally immediately available in most volumes. Uses: Fullerene soot is a carbonaceous material that can be used in a variety of sustainable applications such as double-layer capacitor (dlc), water purification, hydrogen storage, supercapacitor, and nanoelectronics. fullerene soot is a low cost nanomaterial that finds applications in superconductors, photoconductors and semiconductor based industries. Group: Supercapacitorscarbon nano materials. Pack Sizes: 5 g in poly bottle. Product ID: carbon. Molecular formula: 912.81. Mole weight: C60 / C70. [C]. 1S/C. OKTJSMMVPCPJKN-UHFFFAOYSA-N. 99% | 99.9% | 99.99% | 99.999%. |  |
| Fullerene Soot | Fullerene Soot is a fine powder composed of a mix of C60 and C70 fullerenes in a ration of roughly 22% C60 to 76% C70. Fullerene Soot is generally immediately available in most volumes. Uses: Fullerene soot is a carbonaceous material that can be used in a variety of sustainable applications such as double-layer capacitor (dlc), water purification, hydrogen storage, supercapacitor, and nanoelectronics. fullerene soot is a low cost nanomaterial that finds applications in superconductors, photoconductors and semiconductor based industries. Group: other nano materials. Product ID: carbon. Molecular formula: 912.81. Mole weight: C60 / C70. [C]. 99% | 99.9% | 99.99% | 99.999%. | |
| Fullerenols | Fullerenols. Group: Carbon nano materials. | |
| Fullerite (C60/C70 mixture) | Fullerite (C60/C70 mixture). Group: other nano materials. Molecular formula: 720.66/840.77. | |
| Fuller's earth | Fuller's earth. Synonyms: (6R,7R)-8-Oxo-3-(pyridinium-1-ylmethyl)-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate. CAS No. 8031-18-3. Pack Sizes: 1 kg, 5 kg. Product ID: CDC10-0013. Molecular formula: C19H17N3O4S2. Category: Cosmetic Chemical Abrasives. Product Keywords: Cosmetic Ingredients; Cosmetic Chemical Abrasives; Fuller's earth; CDC10-0013; 8031-18-3; C19H17N3O4S2; (6R,7R)-8-Oxo-3-(pyridinium-1-ylmethyl)-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; MFCD00081617; 8031-18-3. Grade: Laboratory Reagent (LR). Color: Beige, grey or brown. Physical State: Powder or granules. Quality Level: 200. Storage: Under proper storage conditions clay may store indefinitely. Application: Cosmetics. Boiling Point: N/A. Melting Point: >1000°C. Density: 0.304-0.737 g/cm3. Product Description: Fuller's Earth, Powder is a palygorskite or bentonite clay material that has the ability to decolorize oil and other liquids. It is typically used as an absorbent for grease or oil. Ungraded products supplied by Spectrum are indicative of a grade suitable for general industrial use or research purposes and typically are not suitable for human consumption or therapeutic use. |  |
| FULLY PROTECTED DEOXYNUCLEOTIDE DIMERD(A PAP) | FULLY PROTECTED DEOXYNUCLEOTIDE DIMERD(A PAP). Uses: Designed for use in research and industrial production. Additional or Alternative Names: EINECS 278-167-6, 3-Adenylic acid, N-benzoyl-5-O-(bis(4-methoxyphenyl)phenylmethyl)-P-(2-chlorophenyl)-2-deoxyadenylyl-(3.5)-N-benzoyl-2-deoxy-,2-chlorophenyl 2-cyanoethyl ester, 75269-16-8. Product Category: Heterocyclic Organic Compound. CAS No. 75269-16-8. Molecular formula: C70H61Cl2N11O15P2. Mole weight: 1429.151564 [g/mol]. Purity: 0.96. IUPACName: [(2R,3S,5R)-5-(6-benzamidopurin-9-yl)-2-[[[(2R,3S,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]oxolan-3-yl]oxy-(2-chlorophenoxy)phosphoryl]oxymethyl]oxolan-3-yl] (2-chlorophenyl) 2-cyanoethyl phosphate. Canonical SMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(CC(O4)N5C=NC6=C5N=CN=C6NC(=O)C7=CC=CC=C7)OP(=O)(OCC8C(CC(O8)N9C=NC1=C9N=CN=C1NC(=O)C1=CC=CC=C1)OP(=O)(OCCC#N)OC1=CC=CC=C1Cl)OC1=CC=CC=C1Cl. ECNumber: 278-167-6. Product ID: ACM75269168. Alfa Chemistry ISO 9001:2015 Certified. |  |
| FULLY PROTECTED DEOXYNUCLEOTIDE DIMER D( APGP) | FULLY PROTECTED DEOXYNUCLEOTIDE DIMER D( APGP). Uses: Designed for use in research and industrial production. Additional or Alternative Names: EINECS 278-844-6, 3-Guanylic acid, N-benzoyl-5-O-(bis(4-methoxyphenyl)phenylmethyl)-P-(2-chlorophenyl)-2-deoxyadenylyl-(3.5)-2-deoxy-N-(2-methyl-1-oxopropyl)-, 2-chlorophenyl 2-cyanoethyl ester, 78111-52-1. Product Category: Heterocyclic Organic Compound. CAS No. 78111-52-1. Molecular formula: C67H63Cl2N11O16P2. Mole weight: 1411.134744 [g/mol]. Purity: 0.96. IUPACName: [(2R,3S,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]oxolan-3-yl] [(2R,3S,5R)-3-[(2-chlorophenoxy)-(2-cyanoethoxy)phosphoryl]oxy-5-[2-(2-methylpropanoylamino)-6-oxo-3H-purin-9-yl]oxolan-2-yl]methyl (2-chlorophenyl) phosphate. Canonical SMILES: CC(C)C(=O)NC1=NC(=O)C2=C(N1)N(C=N2)C3CC(C(O3)COP(=O)(OC4CC(OC4COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)N8C=NC9=C8N=CN=C9NC(=O)C1=CC=CC=C1)OC1=CC=CC=C1Cl)OP(=O)(OCCC#N)OC1=CC=CC=C1Cl. ECNumber: 278-844-6. Product ID: ACM78111521. Alfa Chemistry ISO 9001:2015 Certified. | |
| FULLY PROTECTED DEOXYNUCLEOTIDE DIMER D( CPAP) | FULLY PROTECTED DEOXYNUCLEOTIDE DIMER D( CPAP). Uses: Designed for use in research and industrial production. Additional or Alternative Names: EINECS 278-842-5, 3-Adenylic acid, 5-O-(bis(4-methoxyphenyl)phenylmethyl)-N-benzoyl-P-(2-chlorophenyl)-2-deoxycytidylyl-(3.5)-N-benzoyl-2-deoxy-, 2-chlorophenyl 2-cyanoethyl ester, 78111-50-9. Product Category: Heterocyclic Organic Compound. CAS No. 78111-50-9. Molecular formula: C69H61Cl2N9O16P2. Mole weight: 1405.126864 [g/mol]. Purity: 0.96. IUPACName: [(2R,3S,5R)-5-(4-benzamido-2-oxopyrimidin-1-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]oxolan-3-yl] [(2R,3S,5R)-5-(6-benzamidopurin-9-yl)-3-[(2-chlorophenoxy)-(2-cyanoethoxy)phosphoryl]oxyoxolan-2-yl]methyl (2-chlorophenyl) phosphate. Canonical SMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(CC(O4)N5C=CC(=NC5=O)NC(=O)C6=CC=CC=C6)OP(=O)(OCC7C(CC(O7)N8C=NC9=C8N=CN=C9NC(=O)C1=CC=CC=C1)OP(=O)(OCCC#N)OC1=CC=CC=C1Cl)OC1=CC=CC=C1Cl. ECNumber: 278-842-5. Product ID: ACM78111509. Alfa Chemistry ISO 9001:2015 Certified. | |
| Fulranumab | Fulranumab is a human IgG2 monoclonal antibody against nerve growth factor ( NGF ) and can be used for the research of pain [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 902141-80-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99200. |  |
| Fulranumab | Fulranumab is a human monoclonal antibody against nerve growth factor. Inhibition of the NGF pathway may prevent the perception of pain and may induce analgesia. CAS No. 902141-80-4. |  |
| Fulvestrant | Fulvestrant is a selective estrogen receptor degrader (SERD) that downregulates and degrades estrogen receptor α (ERα).1,2 It binds to rat uterine ER with an IC50 value of 44.8nM and prevents uterine weight increases induced by estradiol in immature rats (ED50> = 0.06mg/kg per day) but has no effect on uterine weight alone.3 It also decreases uterine weight in adult rats without affecting the production of luteinizing and follicle-stimulating hormones and prolactin. Fulvestrant inhibits the growth of ER-positive MCF-7 human breast cancer cells but not ER-negative BT-20 cells when used at a concentration of 1ug/ml. It also prevents tumor growth in MCF-7 and Br10 breast cancer mouse xenograft models when used at a single dose of 5mg per animal. Fulvestrant is neuroprotective in vitro against neurotoxicity induced by glutamate- and amyloid- β (1-42) (A β42) in primary rat hippocampal cells.4 Formulations containing fulvestrant have been used in the treatment of estro Group: Biochemicals. Alternative Names: (7α,17 β ) -7-[9-[4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol; Faslodex; Fulvestrant; ICI 182780; ZD 182780; ZD 9238; ZM 182780. Grades: Highly Purified. CAS No. 129453-61-8. Pack Sizes: 50mg, 100mg. Molecular Formula: C??H??F?O?S, Molecular Weight: 606.77. US Biological Life Sciences. |  Worldwide |
| Fulvestrant | Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC 50 of 9.4 nM. Fulvestrant is also a GPR30 agonist. Fulvestrant effectively inhibits the growth of ER -positive MCF-7 cells with an IC 50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ICI 182780; ZD 9238; ZM 182780. CAS No. 129453-61-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-13636. | |
| Fulvestrant 17-Acetate | Fulvestrant 17-Acetate is a metabolite of Fulvestrant, which is a drug for breast cancer. Synonyms: (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-Acetate; Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, 17-acetate, (7α,17β)-. Grades: 95%. CAS No. 261506-24-5. Molecular formula: C34H49F5O4S. Mole weight: 648.81. | |
| Fulvestrant 17-β-D-Glucuronide | Fulvestrant 17-β-D-Glucuronide is a metabolite of Fulvestrant, which is a drug for breast cancer. Synonyms: (7α , 17β ) -3-Hydroxy-7-[9-[ (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -trien-17-yl β-D-Glucopyranosiduronic Acid; Fulvestrant 17-b-D-glucuronide. Grades: ≥95%. CAS No. 261506-28-9. Molecular formula: C38H55F5O9S. Mole weight: 782.89. | |
| Fulvestrant-17-glucuronide | Grades: > 95%. Molecular formula: C38H55F5O9S. Mole weight: 782.91. | |
| Fulvestrant 3-β-D-Glucuronide 17-Acetate | Fulvestrant 3-β-D-Glucuronide 17-Acetate is a metabolite of Fulvestrant, which is a drug for breast cancer. Synonyms: (7α , 17β ) -17- (Acetyloxy) -7-[9-[ (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -trien-3-yl β-D-Glucopyranosiduronic Acid Triacetate Methyl Ester; β-D-Glucopyranosiduronic acid, (7α , 17β ) -17- (acetyloxy) -7-[9-[ (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -trien-3-yl, methyl ester, triacetate; (7α , 17β ) -17-Acetoxy-7-{9-[ (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl]nonyl}estra-1, 3, 5 (10) -trien-3-yl methyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronate; 7alpha-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-17beta-acetoxy-1,3,5(10)-estratriene-3-yl 2-O,3-O,4-O-triacetyl-beta-D-glucopyranosiduronic acid methyl ester. Grades: >95%. CAS No. 403656-84-8. Molecular formula: C47H65F5O13S. Mole weight: 965.07. | |
| Fulvestrant-3-Glucuronide | Fulvestrant-3-Glucuronide is a metabolite of Fulvestrant. Synonyms: (7a, 17b) -17-Hydroxy-7-[9-[ (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -trien-3-yl b-D-glucopyranosiduronic acid. Grades: > 95%. CAS No. 261506-27-8. Molecular formula: C38H55F5O9S. Mole weight: 782.90. | |
| Fulvestrant-3-Glucuronide Lithium Salt | Fulvestrant-3-Glucuronide Lithium Salt is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C38H54F5O9SLi. Mole weight: 788.83. | |
| Fulvestrant-3-sulfate | Grades: > 95%. Molecular formula: C32H47F5O6S2. Mole weight: 686.85. | |
| Fulvestrant 3-sulfate sodium salt | Fulvestrant 3-sulfate sodium salt. Group: Biochemicals. Alternative Names: (7a,17b)- 7-[9-[ (4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol 3-(hydrogen sulfate) monosodium salt. Grades: Highly Purified. CAS No. 403656-83-7. Pack Sizes: 1mg, 2mg, 5mg, 10mg. Molecular Formula: C32H46F5NaO6S2. US Biological Life Sciences. | Worldwide |
| Fulvestrant 3-Sulfate Sodium Salt | Fulvestrant 3-Sulfate Sodium Salt is a metabolite of Fulvestrant, which is a drug for breast cancer. Uses: A metabolite of fulvestrant (f862500). Synonyms: (7α , 17β ) -7-[9-[ (4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol 3-(Hydrogen Sulfate) Monosodium Salt. Grades: ≥95%. CAS No. 403656-83-7. Molecular formula: C32H46F5NaO6S2. Mole weight: 708.82. | |
| Fulvestrant 3-Sulfooxy 17-Acetate | Fulvestrant 3-Sulfooxy 17-Acetate is a metabolite of Fulvestrant, which is a drug for breast cancer. Molecular formula: C34H49F5O7S2. Mole weight: 728.87. | |
| Fulvestrant ((7µ,17ß)-. 7-[9-[4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol, ICH-182780, Faslodex) | Antineoplastic (hormonal). Group: Biochemicals. Alternative Names: (7µ, 17ß) -7-[9-[4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol; ICH-182780; Faslodex. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Fulvestrant 9-Sulfone | A metabolite of Fulvestrant. Group: Biochemicals. Alternative Names: (7α,17 β ) -7-[9-[ (4, 4, 5, 5, 5-Pentafluoropentyl) sulfonyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol. Grades: Highly Purified. CAS No. 98008-06-1. Pack Sizes: 2.5mg. US Biological Life Sciences. | Worldwide |
| Fulvestrant-9-Sulfone | Fulvestrant-9-Sulfone is a ligand-independent activator of estrogen function. It is a metabolite of Fulvestrant. Synonyms: (7α , 17β ) -7-[9-[ (4, 4, 5, 5, 5-Pentafluoropentyl) sulfonyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol. Grades: > 95%. CAS No. 98008-06-1. Molecular formula: C32H47F5O4S. Mole weight: 622.78. | |
| Fulvestrant Beta-Isomer | Fulvestrant Beta-Isomer, a drug utilized in the management of metastatic breast cancer associated with hormone receptor positivity, acts as a selective estrogen receptor down-regulator that impedes breast cancer cell growth by binding to and disintegrating estrogen receptors. Its modus operandi is to lower the expression of estrogen receptors. Synonyms: (7β , 17β ) -7-[9-[ (4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol; Fulvestrant Impurity A. Grades: > 95%. CAS No. 407577-53-1. Molecular formula: C32H47F5O3S. Mole weight: 606.79. | |
| Fulvestrant-d3 (7-[9-[ (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl]nonyl], (7µ, 17 ß)-Estra-1,3,5(10)-triene-3,17-diol-d3, Faslodex-d3) | Antineoplastic (hormonal). Group: Biochemicals. Alternative Names: 7-[9-[ (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl]nonyl], (7µ, 17 ß)-Estra-1,3,5(10)-triene-3,17-diol-d3; Faslodex-d3. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Fulvestrant-d4 | Fulvestrant-d4. Group: Biochemicals. Alternative Names: (7α,17 β ) -7-[9-[4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol-d4; Faslodex-d4; Fulvestrant-d4; ICI 182780-d4; ZD 182780-d4; ZD 9238-d4; ZM 182780-d4. Grades: Highly Purified. Pack Sizes: 500ug. Molecular Formula: C32H43D4F5O3S, Molecular Weight: 610.799999999999. US Biological Life Sciences. | Worldwide |
| Fulvestrant EP Impurity A | Fulvestrant EP Impurity A. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (7S,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol. CAS No. 407577-53-1. Molecular Formula: C32H47F5O3S. Mole Weight: 606.77. Catalog: APB407577531. |  |
| Fulvestrant EP Impurity B | Fulvestrant EP Impurity B. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfonyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol. CAS No. 98008-06-1. Molecular Formula: C32H47F5O4S. Mole Weight: 622.77. Catalog: APB98008061. | |
| Fulvestrant EP Impurity C | Fulvestrant EP Impurity C. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (7R, 8R, 9S, 13S, 14S, 17S) -13-methyl-7- (9- ( (9- ( (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl) nonyl) sulfinyl) nonyl) -7, 8, 9, 11, 12, 13, 14, 15, 16, 17-decahydro-6H-cyclopenta[a]phenanthrene-3, 17-diol. Molecular Formula: C41H65F5O4S2. Mole Weight: 781.07. Catalog: APB02220. | |
| Fulvestrant EP Impurity C | Fulvestrant EP Impurity C. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2482852-42-4. Molecular Formula: C41H65F5O4S2. Mole Weight: 781.08. Catalog: APB2482852424. | |
| Fulvestrant EP Impurity D | Fulvestrant EP Impurity D. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (8R, 8'R, 9S, 9'S, 13S, 13'S, 14S, 14'S, 17S, 17'S)-7, 7'-(nonane-1, 9-diyl)bis(13-methyl-7, 8, 9, 11, 12, 13, 14, 15, 16, 17-decahydro-6H-cyclopenta[a]phenanthrene-3, 17-diol). Molecular Formula: C45H64O4. Mole Weight: 668.99. Catalog: APB06032. | |
| Fulvestrant EP Impurity D (Fulvestrant Sterol Dimer) (Mixture of Diastereomers) | Fulvestrant EP Impurity D (Fulvestrant Sterol Dimer) (Mixture of Diastereomers). Uses: For analytical and research use. Group: Impurity standards. CAS No. 2483797-59-5. Molecular Formula: C45H64O4. Mole Weight: 669. Catalog: APB2483797595. | |
| Fulvestrant EP Impurity D (Mixture of Diastereomers) | Fulvestrant EP Impurity D (Mixture of Diastereomers) is an impurity of Fulvestrant, which is a selective estrogen receptor degrader (SERD) used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women. Synonyms: Fulvestrant Sterol Dimer; 7,7'-nonane-1,9-diylbis(estra-1,3,5(10)-triene-3,17beta-diol). Molecular formula: C45H64O4. Mole weight: 668.98. | |
| Fulvestrant EP Impurity E | Fulvestrant EP Impurity E. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-9,11,12,13,14,15,16,17-octahydro-8H-cyclopenta[a]phenanthrene-3,17-diol. CAS No. 2170200-14-1. Molecular Formula: C32H45F5O3S. Mole Weight: 604.75. Catalog: APB2170200141. | |
| Fulvestrant EP Impurity F | Fulvestrant EP Impurity F. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-6-one. Molecular Formula: C32H45F5O4S. Mole Weight: 620.75. Catalog: APB02219. | |
| Fulvestrant Extended | Fulvestrant Extended is an impurity of Fulvestrant, an estrogen receptor antagonist used as a medication indicated for the treatment of hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women. Synonyms: (7R, 8R, 9S, 13S, 14S, 17S) -13-methyl-7- (9- ( (9- ( (4, 4, 5, 5, 5-pentafluoropentyl) sulfinyl) nonyl) sulfinyl) nonyl) -7, 8, 9, 11, 12, 13, 14, 15, 16, 17-decahydro-6H-cyclopenta[a]phenanthrene-3, 17-diol. Grades: > 95%. Molecular formula: C41H65F5O4S. Mole weight: 781.09. | |
| Fulvestrant Impurity 1 | Fulvestrant Impurity 1. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-9,11,12,13,14,15,16,17-octahydro-8H-cyclopenta[a]phenanthrene-3,17-diol. Molecular Formula: C32H45F5O3S. Mole Weight: 604.75. Catalog: APB06033. | |
| Fulvestrant Impurity 1 | Fulvestrant Impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2170200-16-3. Molecular Formula: C32H45F5O2S. Mole Weight: 588.76. Catalog: APB2170200163. | |
| Fulvestrant Impurity 1 | Grades: > 95%. Molecular formula: C49H68O6. Mole weight: 753.08. | |
| Fulvestrant Impurity 10 | Fulvestrant Impurity 10 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C32H46BrF5O3S. Mole weight: 685.67. | |
| Fulvestrant Impurity 10 | Fulvestrant Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1807900-80-6. Molecular Formula: C32H47F5O3S. Mole Weight: 606.78. Catalog: APB1807900806. | |
| Fulvestrant Impurity 11 | Fulvestrant Impurity 11 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C32H46BrF5O3S. Mole weight: 685.67. | |
| Fulvestrant Impurity 12 | Fulvestrant Impurity 12 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C32H45Br2F5O2S. Mole weight: 748.56. | |
| Fulvestrant Impurity 13 | Fulvestrant Impurity 13 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C32H45Br2F5O3S. Mole weight: 764.56. | |
| Fulvestrant Impurity 14 | Fulvestrant Impurity 14 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C43H69F5O3S2. Mole weight: 793.13. | |
| Fulvestrant Impurity 15 | Fulvestrant Impurity 15 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C41H65F5O2S2. Mole weight: 749.07. | |
| Fulvestrant Impurity 16 | Fulvestrant Impurity 16 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C49H72O6. Mole weight: 757.09. | |
| Fulvestrant Impurity 17 | Fulvestrant Impurity 17 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C34H49F5O4S. Mole weight: 648.81. | |
| Fulvestrant Impurity 19 | Fulvestrant Impurity 19 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C34H49F5O3S. Mole weight: 632.81. | |
| Fulvestrant Impurity 2 | Grades: > 95%. CAS No. 1621885-80-0. Molecular formula: C30H46O6S. Mole weight: 534.76. | |
| Fulvestrant Impurity 20 | Fulvestrant Impurity 20 is an impurity of Fulvestrant, which is a drug for breast cancer. Synonyms: Estr-4-en-3-one, 17-(acetyloxy)-7-(9-hydroxynonyl)-, (7alpha,17beta)-; DTXSID901198837; (7alpha,17beta)-17-(Acetyloxy)-7-(9-hydroxynonyl)estr-4-en-3-one; (7R,8R,9S,10R,13S,14S,17S)-7-(9-hydroxynonyl)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate. Grades: >98%. CAS No. 875573-64-1. Molecular formula: C29H46O4. Mole weight: 458.67. | |
| Fulvestrant Impurity 3 | Grades: > 95%. CAS No. 1621885-81-1. Molecular formula: C30H44O7S. Mole weight: 548.74. | |
| Fulvestrant Impurity 3 | Fulvestrant Impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 252947-01-6. Molecular Formula: C6H9F5O3S. Mole Weight: 256.19. Catalog: APB252947016. | |
| Fulvestrant Impurity 4 | Grades: > 95%. CAS No. 1621885-82-2. Molecular formula: C30H44O6S. Mole weight: 532.75. | |
| Fulvestrant Impurity 40 | Fulvestrant Impurity 40. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (7R)-7-(9-((tert-butyldimethylsilyl)oxy)nonyl)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate. CAS No. 875573-60-7. Molecular Formula: C35H60O4Si. Mole Weight: 572.43. Catalog: APB875573607. | |
| Fulvestrant Impurity 45 | Fulvestrant Impurity 45. Uses: For analytical and research use. Group: Impurity standards. CAS No. 30956-28-6. Molecular Formula: C2H5ClN2O. Mole Weight: 108.52. Catalog: APB30956286. | |
| Fulvestrant Impurity 5 | Fulvestrant Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2490287-82-4. Molecular Formula: C29H43ClO3. Mole Weight: 475.11. Catalog: APB2490287824. | |
| Fulvestrant Impurity 5 | Fulvestrant Impurity 5 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C34H47F9O3S. Mole weight: 706.78. | |
| Fulvestrant Impurity 6 | Fulvestrant Impurity 6 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C54H82O5S. Mole weight: 843.29. | |
| Fulvestrant Impurity 7 | Fulvestrant Impurity 7 is an impurity of Fulvestrant, which is a drug for breast cancer. CAS No. 1673530-91-0. Molecular formula: C32H47F5O2S. Mole weight: 590.77. | |
| Fulvestrant Impurity 8 | Fulvestrant Impurity 8 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C32H46BrF5O2S. Mole weight: 669.67. | |
| Fulvestrant Impurity 9 | Fulvestrant Impurity 9 is an impurity of Fulvestrant, which is a drug for breast cancer. Molecular formula: C32H46BrF5O2S. Mole weight: 669.67. | |
| Fulvestrant Impurity 9 | Fulvestrant Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1316849-17-8. Molecular Formula: C32H47F5O3S. Mole Weight: 606.78. Catalog: APB1316849178. | |
| Fulvestrant Impurity C | 7-[9-[[9-[ (4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17β -diol (Mixture of Diastereomers) is an impurity of Fulvestrant, which is a drug for breast cancer. Synonyms: 7-[9-[[9-[ (4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17β -diol (Mixture of Diastereomers). Molecular formula: C41H65F5O4S2. Mole weight: 781.07. | |
| Fulvestrant Impurity J | Fulvestrant Impurity J. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (7R,8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate. CAS No. 261506-24-5. Molecular Formula: C34H49F5O4S. Mole Weight: 648.81. Catalog: APB261506245. | |
| Fulvestrant (Standard) | Fulvestrant (Standard) is the analytical standard of Fulvestrant. This product is intended for research and analytical applications. Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC 50 of 9.4 nM. Fulvestrant is also a GPR30 agonist. Fulvestrant effectively inhibits the growth of ER -positive MCF-7 cells with an IC 50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ICI 182780(Standard); ZD 9238(Standard); ZM 182780 (Standard). CAS No. 129453-61-8. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13636R. | |
| Fulvic acid | 25g Pack Size. Group: Biochemicals, Building Blocks, Organics. Formula: C14H12O8. CAS No. 479-66-3. Prepack ID 89988431-25g. Molecular Weight 308.24. See USA prepack pricing. |  |
| Fulvic Acid | Free radical scavenger and antioxidant. Potential compound to neutralize radioactive and toxic wastes and "heal" soils. Chelates and binds scores of minerals into a bioavailable form used by cells. Shown to incorporate into bone and cartilage of rats. Antibacterial. Antifungal. beta-Hexosaminidase release inhibitor. Anti-inflammatory. Tau fibrils aggregation inhibitor (Alzheimers Disease). Antiseptic. Interrupts the dimer formation of Abeta (17-42) peptides. Group: Biochemicals. Alternative Names: 4,10-dihydro-3,7,8-trihydroxy-3-methyl-10-oxo-1H,3H-pyrano[4,3-b][1]benzopyran-9-carboxylic acid. Grades: Highly Purified. CAS No. 479-66-3. Pack Sizes: 1mg, 5mg. Molecular Formula: C??H??O?. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
